Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-02-25 @ 6:36 PM
Study NCT ID:
NCT02592733
Status:
COMPLETED
Last Update Posted:
2018-04-11
First Post:
2015-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001014', 'term': 'Aortic Aneurysm'}], 'ancestors': [{'id': 'D000783', 'term': 'Aneurysm'}, {'id': 'D014652', 'term': 'Vascular Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D001018', 'term': 'Aortic Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 44}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2015-11', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-04', 'completionDateStruct': {'date': '2018-04', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-04-09', 'studyFirstSubmitDate': '2015-10-23', 'studyFirstSubmitQcDate': '2015-10-29', 'lastUpdatePostDateStruct': {'date': '2018-04-11', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2015-10-30', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2017-03', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Radiation Dose (DAP)', 'timeFrame': 'This will be measured during the index operation. There will be no further radiation after that. Investigators expect that this study should take 12 months for full enrollment and analysis', 'description': 'The Dose Area Product acquired in surgery'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'conditions': ['Aortic Aneurysm']}, 'referencesModule': {'references': [{'pmid': '29804734', 'type': 'DERIVED', 'citation': 'Maurel B, Martin-Gonzalez T, Chong D, Irwin A, Guimbretiere G, Davis M, Mastracci TM. A prospective observational trial of fusion imaging in infrarenal aneurysms. J Vasc Surg. 2018 Dec;68(6):1706-1713.e1. doi: 10.1016/j.jvs.2018.04.015. Epub 2018 May 24.'}]}, 'descriptionModule': {'briefSummary': 'This is an observational trial to determine if use of fusion imaging in infrarenal endovascular aneurysm repair will decrease the radiation dose and improve patient safety for this procedure.', 'detailedDescription': "The aorta is the main artery of the body. An aortic abdominal aneurysm (AAA) is defined as an abnormal dilatation of the aorta, based on a diameter of 3 cm or more, due to a weakness of the aortic wall that is prone to rupture, leading to a lifethreatening condition.\n\nOnce AAA diagnosed, a CTscan is required to assess the anatomy and if indicate an endovascular aneurysm repair (EVAR) is performed. This mini invasive procedure allows the exclusion of the AAA by positioning an endograft inside the aorta through a femoral access under live Xrays (fluoroscopy) guidance.\n\nThe Xrays are good at showing bones and radioopaque endovascular tools, but they do not show soft tissues like the aorta, and they produce flat (2D) images that superimpose all the 3D anatomical features. In order to see the aorta, physicians have to inject iodinated contrast during high quality imaging recording. One way to improve clinicians' perception of peroperative 3D vascular anatomy is to accurately overlay selected information from the preoperative CT scan (a 3D vascular mask) onto the live Xray image creating a '3D roadmap'. This advanced imaging application is currently available only in the latest expensive hybrid rooms. This trial will examine the clinical benefits of the first advanced imaging application allowing automated 3D overlay guidance during EVAR in any theatre. The software, combined with secure and certified cloud high performance computing, deduces the patient position from comparing the bony anatomy visible on the Xray to that on the patient's CT scan, enabling it to produce and update accurate and reliable overlays of the diagnostic CT 3D vascular mask throughout the operation (www.cydar.co.uk). Expected benefits include reducing the total Xray exposure of the patients and staff, reduced use of iodinated contrast (a major cause of kidney failure) and shortening procedure duration."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'All patients deemed fit for infrarenal repair at one of 4 centres.', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n1. willing and able to give informed consent,and\n2. aged 18 or older, and\n3. been scheduled for endovascular repair of an infrarenal aortic aneurysm (EVAR), and\n4. who have had a preoperative diagnostic CT scan, and\n5. able (in the investigator's opinion) and willing to comply with the study requirements.\n\nExclusion Criteria:\n\n1. Female participants who is pregnant or planning pregnancy during the course of the study.\n2. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.\n3. Any patient requiring an associated procedure (iliac branch device implantation, renal or mesenteric angioplasty)\n4. Ruptured AAA and emergency procedures"}, 'identificationModule': {'nctId': 'NCT02592733', 'acronym': 'CYDAR-IRAAA', 'briefTitle': 'A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR', 'organization': {'class': 'OTHER', 'fullName': 'Royal Free Hospital NHS Foundation Trust'}, 'officialTitle': 'A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR', 'orgStudyIdInfo': {'id': 'IRAS171317'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Historical Cohort', 'description': 'Patients who have undergone infrarenal endovascular repair at each centre in the past.'}, {'label': 'Prospective Cohort', 'description': 'Patients undergoing infrarenal endovascular repair in the study using CYDAR in addition to the local angiography equipment.', 'interventionNames': ['Device: CYDAR']}], 'interventions': [{'name': 'CYDAR', 'type': 'DEVICE', 'description': 'CYDAR is an automated image mask that is cloud based adn delivered to operating theatres over a secure network. It fuses preoperative images with intraoperative images to provide more accurate image guidance for the surgeon.', 'armGroupLabels': ['Prospective Cohort']}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Tara M Mastracci, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Royal Free Hospital NHS Foundation Trust'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Royal Free Hospital NHS Foundation Trust', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Tara Mastracci, Clinical Lead, Aortic Surgery', 'investigatorFullName': 'Tara Mastracci', 'investigatorAffiliation': 'Royal Free Hospital NHS Foundation Trust'}}}}